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Abstract
Background: Cancer screening programmes in England are publicly-funded. Professionals' beliefs
in the public health benefits of screening can conflict with individuals' entitlements to exercise
informed judgement over whether or not to participate. The recognition of the importance of
individual autonomy in decision making requires greater understanding of the knowledge, attitudes
and beliefs upon which people's screening choices are founded. Until recently, the technology
available required that cancer screening be confined to women. This study aimed to discover
whether male and female perceptions of cancer and of screening differed.
Methods:  Data on the public's cancer beliefs were collected by means of a postal survey
(anonymous questionnaire). Two general practices based in Nottingham and in Mansfield, in east-
central England, sent questionnaires to registered patients aged 30 to 70 years. 1,808 completed
questionnaires were returned for analysis, 56.5 per cent from women.
Results: Women were less likely to underestimate overall cancer incidence, although each sex was
more likely to cite a sex-specific cancer as being amongst the most common cancer site. In terms
of risk factors, men were most uncertain about the role of stress and sexually-transmitted diseases,
whereas women were more likely to rate excessive alcohol and family history as major risk factors.
The majority of respondents believed the public health care system should provide cancer
screening, but significantly more women than men reported having benefiting from the nationally-
provided screening services. Those who were older, in better health or had longer periods of
formal education were less worried about cancer than those who had illness experiences, lower
incomes, or who were smokers. Actual or potential participation in bowel screening was higher
amongst those who believed bowel cancer to be common and amongst men, despite women having
more substantial worries about cancer than men.
Conclusion:  Our results suggest that men's and women's differential knowledge of cancer
correlates with women's closer involvement with screening. Even so, men were neither less
positive about screening nor less likely to express a willingness to participate in relevant screening
in the future. It is important to understand gender-related differences in knowledge and
perceptions of cancer, if health promotion resources are to be allocated efficiently.
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Background
In England, enthusiasm for cancer screening has led to the
establishment of organised national programmes, with
direct costs being met by the publicly-funded National
Health Service (NHS). Since the late-1980s, all women
within prescribed age ranges have been invited routinely
and regularly for testing for breast cancer and for cervical
pre-cancers. The uptake in these two programmes is 75-80
per cent and it is claimed that, over the past 20 years, they
have identified around 100,000 breast cancers and
around 400,000 significant cervical abnormalities [1].
Whilst routine prostate cancer screening remains to be
instituted, eligible men have, since 2002, been entitled to
screening tests on demand, subject to accepting informa-
tion on both the potential benefits and the risks of testing.
A national programme for bowel (colorectal) cancer
screening, using the faecal occult blood test and including
both men and women, was initiated in 2006.
Although health professionals advocate cancer screening
on public health grounds, the prospective participant's
decision to attend for screening is private. The outcome of
that decision depends, in large part, on knowledge, atti-
tudes and concerns with respect both to the disease and to
the process of testing. Most of the research into the pub-
lic's knowledge base conducted to date has been pro-
gramme-specific and, as a consequence, sex-specific,
presumably in view of men's or women's inability to par-
ticipate directly in one or other of the particular screening
services. Typically, only men are asked to provide opin-
ions on screening for prostate cancer and only women are
asked for their views on breast screening [2]. Maintaining
this restricted perspective seems unwarranted, however.
Exclusion from a service on the grounds of incapacity to
benefit personally need not entail disinterest. Most indi-
viduals of screening age are in female-male partnerships
based, presumably, on affection, and one partner's pursuit
of an ostensible risk reduction strategy will impact on the
emotional wellbeing of the other [3]. Indeed, it is proba-
ble that screening decisions in partnerships are actually
made jointly rather than individually [4], implying that
the attitudes of both sexes are influential, irrespective of
whether or not the cancer itself is considered "male" or
"female".
This paper reports the findings of a study of men and
women's beliefs about, and attitudes towards, cancer and
screening. In particular, we were concerned to establish
whether men and women differed in their knowledge of
risk factors and whether one sex was more favourably dis-
posed towards cancer screening than was the other. As it is
traditionally supposed than men are less interested in pre-
ventive medicine than are women [5], significant differ-
ences in knowledge and attitudes might be anticipated.
We also wanted to test, specifically for the case of cancer,
the conclusion of a Scottish study of lay beliefs, namely,
that each sex perceives itself to be more vulnerable than
the opposite sex to major illnesses [6]. We hoped to
expand the "scant literature on gender differences in per-
ceived risk and worry for common diseases" ([7] p. 200).
In the case of cancer, the literature is based almost exclu-
sively on USA-based surveys, wherein women report
higher levels of perceived risk and worry than do men.
Methods
Our data were obtained via a questionnaire survey [addi-
tional file 1], using an instrument designed for self-com-
pletion without supervision. This instrument was based
on those used in previous local studies of screening
knowledge and attitudes [8,9], augmented with questions
suggested by other studies of cancer risk perceptions
[5,10,11]. After initial construction, the instrument and
supporting materials were reviewed for intelligibility by
two lay representatives from the Nottingham Primary
Care Research Partnership Consumer Panel. The docu-
mentation was revised in the light of their observations
and suggestions, presented for ethical approval, and
revised again accordingly.
As with the previous local studies, we sought the assist-
ance of general practitioners in distributing question-
naires. Two practices, one in Nottingham and one in
Mansfield (approximately 12 miles to the north), agreed
to send out questionnaires on our behalf. Although both
practices were urban, the areas served by each differed in
terms of socio-economic deprivation. On the Index of
Multiple Deprivation [12], the latter's area was ranked
3,103 amongst the 32,482 enumeration areas of England,
whilst the former's was ranked 19,572 (rank 1 = most
deprived). The deprivation status of a general practice site
generally proves an adequate proxy for deprivation status
of the population which it serves [13].
The general practitioners were provided with pre-prepared
survey packages, each package containing an invitation
letter, a blank questionnaire, a patient information sheet,
and a pre-paid response envelope for the return of the
completed questionnaire. The practices were asked to
mail packages to registered patients aged between 30 and
70 years, but were granted discretion in exclusion. As with
the previous studies, patients with a current diagnosis of
cancer or with learning disabilities were excluded from the
samples, on the grounds of the need to avoid distress and
incapacity to complete the instrument, respectively. As the
questionnaires were anonymous, we were unable to
enhance compliance by contacting non-responders or to
identify the non-responders' characteristics. All data were
collected in late-2007 and, as far as the results reported
here are concerned, all questions were closed-ended
(mostly of the tick-box variety).BMC Public Health 2009, 9:431 http://www.biomedcentral.com/1471-2458/9/431
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The opening section of the questionnaire was entitled:
"What do you know about cancer?". Subjects were asked,
first, to estimate the number of newly-diagnosed cancer
cases each year, by selecting one of six numerical values
(125,000 to 500,000, in steps of 75,000). As the true
number lay between 275,000 and 350,000 [14], values of
125,000 and 200,000 were classified as under-estimates
of incidence, and those of 425,000 and 500,000 were clas-
sified as over-estimates. Second, subjects were asked to
select (in effect, to vote for) "the two most common can-
cers" in the UK from an alphabetical list of six, namely,
bowel (colorectal), breast, cervical, lung, prostate, skin
(melanoma). Epidemiologically, the adjective "most
common" is ambiguous and might be taken to refer to
incidence, to prevalence or to mortality. The imprecision
in phrasing was chosen deliberately, however, on the
expectation that respondents would be more comfortable
with intuitive than with technical phrasing [15]. Whilst
the correct answer to this second question is therefore
equivocal, the imprecision does not affect our ability to
interpret subject response. For some time, the two cancers
with the highest incidence have been breast and lung,
closely followed by bowel [14]. Lung and bowel are the
two most common causes of cancer-related death [16],
whilst breast and bowel have the highest prevalences in
the population [17]. It follows that, irrespective of inter-
pretation, prostate cancer, melanoma or cervical cancer
cannot be considered amongst the "two most common".
Indeed, the incidence of cervical cancer is particularly low
in England, owing to the effectiveness of the national
screening programme.
Subjects were asked to rate each of eight cancer risk factors
as a major risk, a minor risk, or as no risk. A "don't know"
option was also available. We included increasing age,
smoking tobacco and over-indulgence in alcohol use, all
of which are generally presumed by health professionals
to represent principal risk factors for most forms of cancer.
We included being overweight and a lack of exercise,
which are known to be risk factors for some of the more
common cancers, such as breast and bowel. Sexually-
transmitted infection is relevant for a few specific cancers
only, although the association between human papillo-
mavirus and cervical cancer is being publicised increas-
ingly. We included two factors which are commonly-cited,
although less-well-validated. These were, first, a family
history of cancer (genetic risk), even though it "is uncom-
mon for cancer to run in a family... Most of the time, mul-
tiple cases of cancer in a family are just a matter of chance"
([18] p.15). Second, we included persistent stress and anx-
iety, in spite of the association between stress and cancer
remaining equivocal [19].
Each subject was offered three true-or-false questions,
namely, whether sun-bathing caused skin cancer, whether
cancer was more common amongst women than it was
amongst men, and whether more people died of heart dis-
ease than died of cancer. The first statement, of course, has
long been accepted as true by both practitioners and pub-
lic alike [20,21] and we expected most, if not all, subjects
to respond accordingly. The numbers of males and of
females dying from cancer each year are approximately
equal, as are the numbers of new cases diagnosed. Age-
standardised rates for males, however, have long been sig-
nificantly higher than those for females [22]. The relative
importance of cancer and heart disease is a question of
interpretation: "At all ages, there are more deaths from
cancer than from ischaemic heart disease. However, no
single cancer is a more common cause of death than
ischaemic heart disease" ([23] p.16). It should be stressed
that the study was less concerned with subjects being
objectively wrong or right in their knowledge and more
concerned with the existence of differences in response
between the sexes.
Three types of cancer screening currently available via the
NHS - bowel, breast and prostate - were described briefly.
We restricted discussion to these three types, on the
grounds that men and women would each be eligible for
two types only. We asked the respondents whether they
believed that the NHS should continue to provide screen-
ing services such as these. They were also asked to indicate
whether they had already been screened, or whether or
not they would accept a test were one to be offered.
The final section of the questionnaire was modelled
closely on the instruments used in previous local studies
[8,9]. It requested socio-demographic information includ-
ing sex, age, marital status, and age on leaving full-time
education. Ethnic origin was to be identified as one of
African, Afro-Caribbean, Asian, Chinese, White or
"other". Annual household income was represented by a
choice of one from four income bands, beginning at 0-
£10,000 and thereafter in increments of £10,000 to
£30,000 and above. An individual with average house-
hold income in and around the Nottingham would have
selected the £20-30,000 band [24]. We requested an indi-
cation of smoking status (current smoker, ex-smoker,
never smoked) and subjects' perception of their weight
(over-, under-, about right). Subjects reported illness expe-
riences, i.e. whether they or a close family member had
ever suffered from each of six conditions (stomach com-
plaints, piles or haemorrhoids, heart disease, cancer,
stroke, depression). We invited subjects to indicate their
degree of worry about the prospect of cancer (4-point
scale: not worried, minor concerns, quite worried, very
worried). To assess personal risk perception, we invited
respondents to assess their own chances of getting cancer,
relative to people of their own age and sex (5-point scale:
much less, less, the same, more, much more). SubjectsBMC Public Health 2009, 9:431 http://www.biomedcentral.com/1471-2458/9/431
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described their current states of health by completing
standard EQ-5D (EuroQoL) health state classifications
[25]. Classified states were translated into EQ index scores
using to the current UK tariff [26].
We planned two types of analysis. First, responses to the
factual questions, such as estimated incidence, identity of
most common cancers and risk factors, were examined
with respect to male-female differences in proportions.
Beyond establishing whether men's and women's judge-
ments were accurate, we were concerned to establish
whether opinions differed systematically by sex. Second,
three specific beliefs or attitudes about cancer and screen-
ing were modelled using logistic regressions, again with a
view of establishing the existence, or otherwise, of male-
female differences. The dependent variables in the regres-
sions were (i) the belief that the chances of getting cancer
were above average, (ii) having substantial concerns
about cancer, and (iii) actual or potential participation in
bowel cancer screening. We restricted the analysis of par-
ticipation to bowel screening, as this was the only type for
which both sexes were eligible. All of the socio-demo-
graphic and knowledge variables were candidates for the
models initially, which were re-estimated after excluding
variables with insignificant coefficients.
Results
Out of 6,939 questionnaires distributed, 1,808 were com-
pleted and returned for analysis. The response rate (26.1
per cent) was similar to that achieved in a previous local
study [9]. Of those questionnaires returned, 1,016 (56.5
per cent) had been completed by women. Table 1 displays
the socio-demographic characteristics of the sample. The
male and female sub-samples did not differ significantly
with respect to years of full-time education, ethnicity,
cohabitation status, current health (EQ index score) and
weight perception. Women, however, were younger on
average, and were more likely to drawn from lower
income households. Significantly more women than men
had illness experiences, for all six of the conditions nom-
inated. Although the proportion of current smokers was
similar between sub-samples, a higher proportion of
women had never smoked.
Table 2 displays the responses to the first two factual ques-
tions. Identifying the "most common" cancers by means
of a simple count of subjects' votes (two per subject) pro-
duced an overall ranking broadly consistent with any of
the interpretations of the phrase, namely, breast, bowel,
lung, prostate, skin and cervical. Even so, more than one-
quarter of the votes (27.9 per cent) were cast for cancers
which could not be considered common by any interpre-
tation. Comparing the male/female sub-samples, equal
proportions of men and women believed breast, lung or
skin cancer to be amongst the two most common. How-
ever, a significantly higher proportion of women believed
bowel or cervical cancer to be one of the two most com-
mon, whereas a significantly higher proportion of men
believed prostate cancer to be one of the two most com-
mon. Proportionately fewer women than men under-esti-
mated overall cancer incidence.
Table 3 presents the proportion of subjects' declaring an
inability to judge the level of risk represented by the vari-
ous risk factors. The factors about which most subjects
were uncertain (i.e. the highest proportion of "don't
Table 1: Socio-demographic characteristics
Women Men t or χ2 p =
Mean age, years 49.7 52.3 -4.88 0.00
Mean age leaving full-time education, years 17.4 17.4 -0.18 0.86
Ethnicity, % white 97.7 96.9 1.17 0.28
Married or with a partner, % 77.7 80.3 1.86 0.17
Annual household income, % Up to £10,000 18.4 16.3 10.24 0.02
£10-20,000 29.4 23.9
£20-30,000 16.8 19.1
Above £30,000 35.3 40.6
Mean EQ index score 0.82 0.83 -0.81 0.42
Illness experience, % Stomach problems 41.2 35.1 7.02 0.01
Piles/haemorrhoids 48.8 61.8 30.19 0.00
Heart disease 44.8 37.8 8.89 0.00
Cancer 62.1 46.7 42.00 0.00
Stroke 34.1 29.6 4.12 0.04
Depression 49.1 34.8 36.53 0.00
Tobacco smoking, % Current smoker 14.8 14.0 36.67 0.00
Ex-smoker 27.8 41.2
Never smoked 56.5 43.5
Considers self to be overweight, % 39.7 38.8 0.15 0.70BMC Public Health 2009, 9:431 http://www.biomedcentral.com/1471-2458/9/431
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know" responses in assigning a risk level) were stress and
sexually-transmitted diseases, significantly more so for
men in the case of the latter. Scientifically speaking, the
response was appropriate in the first case but less so in the
second. The risk factors about which most subjects
expressed certainty (i.e. the lowest proportion of "don't
know" responses) were tobacco smoking and family his-
tory, significantly less so for men in the case of the latter.
Only one individual responded "don't know" to all eight
risk factors.
Table 4 indicates risk assessments for those who felt able
to judge. For the whole sample, the ranking of potential
factors dismissed as irrelevant to cancer risk were, in
descending order, lack of exercise, stress, sexually-trans-
mitted disease, being overweight, age, alcohol, family his-
tory, smoking. The risk factors considered to be major by
the most subjects were smoking, excessive alcohol con-
sumption and family history, significantly more so by
women in the case of the last two. Compared with men,
women assigned a higher risk status to sexually-transmit-
ted diseases, but there were no differences of opinion
between men and women as regards weight, exercise, age
and stress. The most common (n = 35) combination of
responses to the risk factor questions was to identify all as
major risks, closely followed (n = 28) by assigning smok-
ing, family history and age as major risks, with the
remainder as minor risks.
With respect to the three true-or-false questions, nearly all
subjects (98.7 per cent) agreed that sun-bathing was a skin
cancer risk. The majority (53.3 per cent) did not accept
that cancer was more common amongst women than it
was amongst men, although 26.2 per cent reported "don't
know". Two-fifths of the sample (41.5 per cent) thought
(incorrectly) that more people died of heart disease than
died of cancer, with 25.9 per cent reporting "don't know".
For none of these questions did the proportions of male
and female responses differ significantly (χ2 test, p = 0.21
or greater). A "don't know" response to both of the last
two questions was offered by 10.1 per cent of the sample,
with no significant difference between the sexes (χ2 =
0.01, p = 0.92).
Virtually the entire sample (99.6 per cent) believed that
cancer screening services should continue to be provided
by the National Health Service. For breast cancer screen-
ing, 47.4 per cent of women reported that they had
already been screened, and a further 48.4 per cent indi-
cated that they would take the test, were one to be offered.
The corresponding proportions for prostate cancer screen-
ing amongst men were 7.4 per cent and 83.6 per cent,
respectively. The higher rate of actual participation in
breast cancer screening is to be expected, in view of the
longer duration and higher public profile of that pro-
gramme. Combining the actual and potential participa-
tion percentages, the proportion of women positively
receptive to breast cancer screening was higher than the
Table 2: Beliefs about prevalence and incidence
% of votes cast % voting for each cancer as one of the two most common:
Women Men χ2 p =
Two most common cancers
Bowel 19.0 41.3 32.9 13.24 0.00
Breast 37.5 74.7 73.6 0.32 0.57
Cervical 4.2 10.1 6.0 9.41 0.00
Lung 15.6 30.3 31.8 0.48 0.49
Prostate 14.1 21.6 35.9 44.97 0.00
Skin (melanoma) 9.6 19.3 18.7 0.10 0.75
Estimated cancer incidence
Over-estimate 34.7 33.2 5.93 0.05
Correct 44.2 40.7
Under-estimate 21.2 26.1
Table 3: Proportion (%) unable to assign a level of risk to a risk 
factor
Risk factor % χ2 p =
Being overweight Women 10.7 0.10 0.76
Men 11.2
Smoking tobacco Women 0.0 2.59 0.11
Men 0.3
Too much alcohol Women 7.1 0.05 0.82
Men 6.8
Lack of exercise Women 11.0 0.74 0.39
Men 9.8
Sexually-transmitted diseases Women 13.9 6.32 0.01
Men 18.3
Family history/genetic Women 1.0 9.21 0.00
Men 2.9
Increasing age Women 7.3 1.13 0.29
Men 6.0
Stress and anxiety Women 16.3 0.80 0.37
Men 14.8BMC Public Health 2009, 9:431 http://www.biomedcentral.com/1471-2458/9/431
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proportion of men receptive to prostate cancer screening
(95.8 vs. 91.0 per cent, Z = 4.11, p < 0.01). Interest in
bowel cancer screening was slightly lower, with 6.8 per
cent of men and women reporting a previous screen, and
a further 80.3 per cent indicating a wish to be tested. Most
people in the sample (69.6 per cent) assessed their
chances of getting cancer as the same as the average for
their age and sex, although 15.3 and 15.1 per cent
believed that their chances were higher and lower, respec-
tively. Most subjects (75.5 per cent) recorded either no or
minor worries about cancer, the remainder having more
substantial concerns (quite or very worried).
Tables 5, 6 and 7 present the final versions of the three
logistic regression models. Being older or in better health
made individuals less likely to have substantial worries
about cancer or to perceive their cancer risk to be above
average. Those with longer periods of formal education
were also less likely to have cancer worries. Illness experi-
ences, especially an experience of cancer, increased the
likelihoods of a perceived higher risk, cancer worries and
enthusiasm for bowel cancer screening. Correspondingly,
those expressing no worries about cancer were less-favour-
ably disposed towards bowel screening. Those from lower
income bands were more likely to be worried about can-
cer but less likely to embrace screening. Smokers saw
themselves to be at higher risk of cancer, especially if they
believed lung cancer to be common, although they were
comparatively unenthusiastic about bowel screening. As
might have been anticipated, under-estimating cancer
incidence reduced the likelihood of seeing oneself to be at
risk, whilst believing bowel cancer to be common
increased the likelihood of being favourably disposed
towards bowel screening. Those considering themselves
overweight believed they faced a greater cancer risk.
Finally, women were more likely than men to have sub-
stantial worries about cancer, yet were less likely to be
favourably disposed towards bowel screening. It should
be noted that, for none of the models, were the coeffi-
Table 4: Level of risk assigned (% of those assigning a level)
Risk factor Major Minor None χ2 p =
Being overweight Women 32.3 53.8 13.8 0.77 0.68
Men 31.6 53.0 15.4
Smoking tobacco Women 97.4 2.6 0.0 0.13 0.72
Men 97.7 2.3 0.0
Too much alcohol Women 48.9 42.2 8.9 11.55 0.00
Men 40.6 48.0 11.3
Lack of exercise Women 15.8 58.5 25.7 2.75 0.25
Men 15.4 55.2 29.4
Sexually-transmitted diseases Women 36.7 47.5 15.8 44.48 0.00
Men 23.2 49.7 27.1
Family history/genetic Women 77.7 22.0 0.3 21.27 0.00
Men 71.2 26.4 2.4
Increasing age Women 33.8 52.7 13.5 3.86 0.14
Men 36.7 52.8 10.5
Stress and anxiety Women 25.1 53.7 21.2 1.46 0.48
Men 25.7 50.8 23.4
Table 5: Logistic regression: Chances of getting cancer believed to be above average = 1
Variables β Odds ratio 95% CI
Constant -1.14
Age, years -0.03 0.97 0.96 - 0.98
Experience: stomach problems = 1 0.29 1.34 1.00 - 1.80
Experience: heart disease = 1 0.31 1.36 1.01 - 1.83
Experience: cancer = 1 1.49 4.46 3.12 - 6.37
EQ index score -0.90 0.41 0.23 - 0.73
Current smoker = 1 1.17 3.21 2.24 - 4.59
Overweight = 1 0.58 1.78 1.32 - 2.40
Cancer incidence under-estimated = 1 -0.45 0.64 0.44 - 0.93
Smoking and lung cancer* = 1 0.60 1.83 1.25 - 2.67
Nagelkerke R2 0.22
* those with a history of smoking who believe lung cancer to be amongst the two most common.BMC Public Health 2009, 9:431 http://www.biomedcentral.com/1471-2458/9/431
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cients associated with ethnicity, marital status and general
practice of origin statistically significant.
Discussion
Our results did not confirm fully the hypothesis that each
sex feels itself to be more vulnerable than the opposite sex
to cancer [6]. In our sample, men and women responded
in approximately equal proportions when asked directly
whether cancer was more common amongst members of
one sex than amongst those of the other. Neither sex
believed disproportionately that cancer was more or less
destructive than heart disease. This having been said,
women were more likely to suggest cervical cancer
(female-specific) as one of the common types, whereas
men were more likely to suggest prostate cancer (male-
specific). As strict factual accuracy would have required
neither to have been selected, the inaccuracies themselves
are consistent with the vulnerability hypothesis. The belief
amongst women that cervical cancer is widespread in Eng-
land has been observed before [27] and can be ascribed in
part to the social amplification of risk engendered by the
national screening programme [9]. Bowel cancer featured
less prominently amongst men's rankings than it did
amongst women's in our sample. Bowel cancer is much
less common than prostate cancer within the set of can-
cers to which men specifically are susceptible, although it
and lung cancer would rank in second place for specifi-
cally-female cancers. This having been said, bowel cancer
in England has a higher incidence amongst men than it
has amongst women.
Although there exist few other both-sex studies of beliefs
about cancer in general, several single-sex studies or both-
sex studies of one or more cancer types have been under-
taken. Several of our risk factor findings parallel those of
earlier studies. First, age was under-rated as a risk factor for
cancer by both men and women equally, being assessed as
a major risk only by around one-third of subjects. An ear-
lier British population study [10] also reported a compar-
ative disregard for age as a risk, as did studies of specific
cancer types, such as breast [28] and bowel [29]. Second,
particular prominence was accorded to the family history
and the genetic basis of cancer, particularly by women. A
similar finding was reported by an American population
study [30] and a British study of bowel cancer awareness
[31]. Family history was the most frequently chosen risk
in women-only studies of cervical cancer [9,32,33],
although it is evident that such a belief can prevail
amongst men also [34]. Third, high perceived risks from
smoking were also reported equally for both sexes in the
cited British population study [10], whilst those posed by
both alcohol and smoking were similarly reported in an
English study organised, like ours, via general practice
[27].
Where the assignment of a risk factor's severity differed
significantly by sex (Table 4), women rated that factor
Table 6: Logistic regression: Quite or very worried about cancer = 1
Variables β Odds ratio 95% CI
Constant 2.43
Sex, male = 1 -5.15 0.60 0.46 - 0.77
Age, years -0.04 0.97 0.96 - 0.98
Age leaving full-time education, years -0.07 0.93 0.89 - 0.98
Income, £10-20,000 = 1 0.37 1.45 1.11 - 1.90
Experience: haemorrhoids = 1 0.26 1.30 1.02 - 1.66
Experience: heart disease = 1 0.26 1.29 1.01 - 1.65
Experience: cancer = 1 0.48 1.62 1.26 - 2.08
EQ index score -1.25 0.29 0.17 - 0.48
Nagelkerke R2 0.12
Table 7: Logistic regression: Has accepted, or would accept, an offer to be screened for bowel cancer = 1
Variables β Odds ratio 95% CI
Constant 1.65
Sex, male = 1 0.57 1.76 1.28 - 2.42
Income, < £10,000 = 1 -0.97 0.38 0.27 - 0.53
Experience: stomach problems = 1 0.50 1.65 1.19 - 2.28
Experience: cancer = 1 0.46 1.59 1.17 - 2.16
Current smoker = 1 -0.53 0.59 0.40 - 0.86
Bowel cancer believed to amongst the two most common = 1 0.49 1.64 1.18 - 2.27
No worries about cancer = 1 -0.76 0.47 0.33 - 0.65
Nagelkerke R2 0.10BMC Public Health 2009, 9:431 http://www.biomedcentral.com/1471-2458/9/431
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more highly, and similar finding was reported in a Japa-
nese population study [35]. In the Japanese sample, infec-
tions, smoking, stress and endocrine-disrupting chemicals
(EDCs) were rated as the main sources of risk, with lack of
exercise, being overweight and alcohol being considered
relatively unimportant. As this particular study was con-
cerned with knowledge of avoidable risk, age and family
history were not available to be identified as risk factors.
The authors ascribed the precedence given to infections
and chemicals to intense recent media coverage of both
EDCs and a contemporary epidemic of Sudden Acute Res-
piratory Syndrome. By the same token, it is possible that
the recognition of alcohol and sexually-transmitted dis-
ease risk by women in our sample follows from the Eng-
lish media's sustained coverage of the health
consequences of the supposedly-upward trend in drinking
and sexual promiscuity amongst younger women [36].
The earlier British study [10] included so-called "mythic
causes" of cancer (food additives, proximity to overhead
power lines, pollution and stress) in its range of risk factor
options, "mythic causes" being behaviours or sets of cir-
cumstances whose associations with cancer remain to be
established scientifically. Leaving aside the question as to
whether or not such factors genuinely are mythic, rela-
tively few subjects in that study were convinced of the
importance of the first three, although stress was cited by
up to 25 per cent of respondents. In our own study, over
60 per cent of both men and women considered stress to
be a risk factor. Stress was considered an important risk
factor in the Japanese sample [35], as it was by subjects in
an Irish study of breast cancer [37]. In none of these stud-
ies was a differential response by gender reported. How-
ever, when actual cancer patients in the USA were asked to
assign causes for their condition, stress was posited as a
causal factor by around 20 per cent of men but by around
40 per cent of women [38].
Our regression analysis suggested that comparative risk
perception was positively associated with illness experi-
ences, smoking and being overweight, negatively associ-
ated with age and the current level of general health, and
unrelated to gender. This result merits comparison with
those of two USA population studies. First, a regression
analysis of routinely-collected national socio-demo-
graphic and health data indicated that a high perceived
absolute risk of cancer was negatively associated with age
and positively associated with current smoking, alcohol
consumption, having one or more relatives with cancer,
low income, with being obese (but not with being over-
weight), and with being female [39]. In the second study
[40], high perceived relative risk was negatively associated
with age and with general health, and positively associ-
ated with a family history of cancer and being male. In so
far as the American findings can be pooled, they seem to
mirror our finding that current health status, family can-
cer, smoking and age are robust predictors of risk percep-
tion, whilst the significance of gender remains equivocal.
The variables in our model predicting heightened worries
about cancer (having a family experience of cancer, being
less educated, being younger or in poorer health, and
being female) are also reported as significant in the anal-
ysis and attendant literature review of the second US study
cited above [40]. Neither analysis included family experi-
ences of illness other than cancer which emerged as signif-
icant predictors of worry in our model. Our findings are
consistent with those of a US study [7] concluding that
women worry more about cancer than do men, and with
those of a study reporting that worry about, and perceived
risk of, one serious disease such as cancer, heart disease or
diabetes is influenced positively by the presence of both
that disease and other such serious diseases amongst fam-
ily members [11].
Contrary to the supposition that men are less interested in
preventive medicine than are women [5], almost everyone
in our study, irrespective of sex, agreed that NHS should
be providing cancer screening services. Such widespread
agreement might be a reflection of the way health care is
financed in England; all individuals contribute to the
NHS via tax contributions related to ability to pay and
unrelated to whether or not health care is actually con-
sumed. Thus, men have always contributed to the costs
women's care services, and vice versa. Despite men's inter-
est in prostate cancer screening being lower than women's
interest in breast cancer screening, more than 90 per cent
remained favourably disposed towards testing. The dis-
parity in interest by sex must be explicable in part by the
weight of publicity attached to the national breast screen-
ing programme in England, contrasting with the NHS's
deliberately-discreet approach towards prostate screening.
Indeed, it is probable that men are currently over-recep-
tive to prostate cancer screening. Men-only studies both in
Sweden [41] and in England and Wales [42] show that
knowledge levels about the disease and the consequences
of screening are typically low, although attitudes towards
testing are uniformly positive. Health education, in the
form of the provision of authoritative information, signif-
icantly reduces the propensity to demand prostate screen-
ing. Ostensibly countering the stereotype, our logistic
regression result predicts that an interest in bowel cancer
screening is more probable amongst men. Although there
is some US evidence to support of this finding [43], it is
inconsistent with that of another English survey [44] and
also with English experience prior to the recent imple-
mentation of the national faecal occult blood screening
programme. Participation was significantly higher
amongst women than amongst men in both the English
randomised controlled trial [45] and the programme's
pilot phase [46].BMC Public Health 2009, 9:431 http://www.biomedcentral.com/1471-2458/9/431
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Our study has limitations. We elected to distribute ques-
tionnaires via general practitioners rather than by direct
mailing. Experience has shown that this method achieves
a much higher response rate, albeit at the risk of introduc-
ing bias. In the absence of detailed information on each
subject offered a questionnaire, response bias by charac-
teristic cannot be ascertained. Despite guidance from the
investigators, practitioners' exclusions of potential
respondents remained discretionary and unrecorded,
although it is probable that the sample excluded a dispro-
portionate number of subjects with cognition difficulties
or with particularly close contacts with cancer. This having
been said, detailed analyses of respondents in local bowel
[47] and cervical [9] screening studies, which also used
the general practice distribution method, failed to provide
evidence of systematic differences in characteristics
between samples and populations. Of possibly more sub-
stance with respect to possible bias concerns the findings
with respect to bowel cancer. The Nottingham area has
hosted the national clinical trial of bowel screening since
the 1980s. The trial has never been widely publicised, yet
it's very scale must have familiarised many local people
with the condition and the procedure. It is therefore prob-
able that Nottingham's views on bowel cancer are not,
strictly speaking, representative of those of rest of the
country.
Conclusion
The development of national cancer screening services in
England has strongly favoured women's health promo-
tion opportunities compared with those of men's, owing
to both biology and technology. Not surprisingly, in view
of the nature of service provision, far fewer men than
women in our sample had experienced screening. Given
women's greater involvement in the process, therefore, we
had anticipated that knowledge of cancer and attitudes
towards screening would vary with sex. Compared with
women, men were more likely to underestimate cancer
incidence. Whilst neither sex believed themselves to be
more susceptible to cancer per se, each did believe a same-
sex-specific cancer to be amongst the most common types.
With respect to sexually-transmitted infections and family
history as risk factors, men were more likely to admit
ignorance, and less likely to perceive each as a major risk.
In reality, each of these factors is more significant for
female-specific cancers (notably, cervical and breast,
respectively). Overall, our results suggest that knowledge
of cancer correlates with women's closer involvement
with screening. This having been said, men were neither
less positive about screening nor less likely to express a
willingness to participate in relevant screening in future,
suggesting that personal experience alone fails to explain
attitudes. Although women expressed more worries about
cancer, men expressed the greater interest in bowel cancer
screening.
Given differential knowledge, it is inevitable that differ-
ences exist between the sexes in the process of reaching
screening decisions. In the past, health education and
health promotion programmes have remained "gender
blind", yet presuming gender or sex to be irrelevant to
how people perceive and comprehend is a potential
obstacle to the development of effective health promotion
policies [48]. International organisations are emphasising
gender as both fundamental and integral to health care
analysis and policy [49], and the findings of this study
endorse the importance of research into gender-based ine-
qualities in the provision of cancer services in England
[50].
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